Mobic (Meloxicam)

Meloxicam works by preferentially inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which reduces the production of prostaglandins—chemicals that drive inflammation, pain, and fever. This selective COX‑2 inhibition provides anti‑inflammatory and analgesic effects while sparing COX‑1 activity that protects the stomach lining.

The appropriate dose of Mobic is determined by the prescribing healthcare professional based on the patient’s condition, age, renal and hepatic function, and response to therapy. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety data for meloxicam in pregnancy and lactation are limited. Because NSAIDs can affect fetal cardiovascular development and may pass into breast milk, Mobic is generally avoided unless the potential benefit justifies the risk. Consultation with a healthcare provider is essential.

To order Mobic, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Mobic (meloxicam) offers more selective COX‑2 inhibition than non‑selective NSAIDs like ibuprofen, potentially providing comparable pain relief with a lower incidence of gastrointestinal irritation. However, both drug classes share risks of cardiovascular and renal adverse effects, so choice depends on individual patient factors.

Mobic should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Mobic is taken orally, usually as a tablet swallowed whole with a full glass of water. It may be taken with or without food, but taking it with food can help reduce possible stomach upset. Follow the prescriber’s dosing schedule.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, severe kidney injury, liver toxicity, and allergic reactions like anaphylaxis. Patients should seek immediate medical attention if they experience symptoms such as severe abdominal pain, chest pain, sudden swelling, or rash.

Mobic should be avoided in individuals with known hypersensitivity to meloxicam or other NSAIDs, active gastrointestinal ulcers or bleeding, severe renal or hepatic impairment, uncontrolled hypertension, and in patients who have had recent coronary artery bypass surgery or other major cardiovascular events.